#Foley Catheter Market

[bhushans]

The Rise of Tech-Driven Therapies: Reshaping the Global Foley Catheter Market

The  foley catheter market sales are anticipated to attain US$ 1,565 million by 2023. Between 2023 and 2033, the market is projected to develop at a compound annual growth rate (CAGR) of 5.4%, valuing itself at US$ 2,641 million by then.

Sales of Foley catheters are rising swiftly, indicating ongoing advancements in medical technology and patient care. The foley catheter is a vital piece of medical equipment used in the treatment and relief of urological issues. The aging population, which has a higher frequency of urinary illnesses, technological developments in catheter design, and raised awareness of urological diseases are some of the factors propelling the market’s growth. The Foley catheter market is still at the forefront, changing and adapting to meet the

Since urological conditions such urinary obstruction, bladder retention, and incontinence are becoming more prevalent, the market for foley catheters has been expanding gradually. According to the National Institutes of Health, around 50% of women who are 65 years of age or older experience urine incontinence. Furthermore, it is expected that the need for foley catheters will be driven throughout the projected period by the aging population and the rise in chronic renal disorders.

Preview Next-Level Insights Sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

A major driver of the foley catheter industry is the increasing acceptance of less invasive surgical methods. These therapies are getting more and more popular because to their shorter recovery times and lower risk of consequences. Since many minimally invasive treatments need the use of foley catheters, this factor is anticipated to fuel market expansion over the course of the projected period.

Nevertheless, there are a number of obstacles facing the foley catheter business, including CAUTIs, or catheter-associated urinary tract infections. CAUTIs are linked to higher healthcare expenses and are a major source of morbidity and mortality among hospitalized patients. As a result, novel catheter coatings and materials have been created that can lower the risk of CAUTIs..

The growing competition from complementary therapies like sacral nerve stimulation and pelvic floor muscle training presents another difficulty for the foley catheter market. Because of these non-invasive methods’ long-term efficacy, they are becoming more and more well-liked. This is predicted to partially impede the market’s growth for foley catheters.

The foley catheter market is anticipated to expand throughout the forecast period in spite of these obstacles. A growing number of people are becoming older, urological problems are becoming more common, and less invasive surgical techniques are becoming more and more popular, all of which are contributing to this growth. Businesses in the foley catheter sector must concentrate on creating cutting-edge catheter coatings and materials that can lower the risk of CAUTIs and enhance patient outcomes if they want to stay competitive.

Key Takeaways from the Foley Catheter Market:

The top product in the foley catheter industry is the 2-way catheter, which is expected to rise at a CAGR of 8.8% from 2023 to 2033.

Hospitals are the top-end user of the foley catheters industry, with a projected CAGR of 8.8% during the forecast period.

The United States foley catheters industry is expected to reach US$ 756.7 million by 2033, with a CAGR of 5.7% during the forecast period.

China is expected to see a CAGR of 5.9% from 2023 to 2033, with a market size of US$ 119.9 million by 2033.

The Canada foley catheters industry is expected to reach US$ 102.1 million by 2033, with a CAGR of 4.0% during the forecast period.

Germany is expected to see a CAGR of 5.9% during the forecast period, with a market size of US$ 111.7 million by 2033.

The United Kingdom foley catheters industry is expected to reach US$ 159.5 million by the end of the forecast period during the forecast period, with a CAGR of 5.8% from 2023 to 2033.

Rise of Antimicrobial Coatings and Silicone-based Catheters Fuels Competition in the Market

The global foley catheter industry is highly competitive, with numerous sizable companies operating in the market. The market is characterized by the presence of several leading players, along with numerous regional players and new entrants.

The industry is dominated by prominent players such as B. Braun Melsungen AG, Coloplast A/S, Cook Medical LLC, CR Bard Inc., Medline Industries Inc., and Teleflex Inc. These companies are well-established and have a strong presence in the global market. They focus on developing innovative and advanced products to maintain their position in the market. These players also engage in strategic collaborations, partnerships, and mergers and acquisitions to expand their business and enhance their product portfolio.

In addition to the key players, several regional players also play a significant role in the market. These companies focus on catering to the specific needs of their respective regions. They offer cost-effective and customized products to their customers. Regional players include companies such as Hollister Incorporated, Manfred Sauer GmbH, and Bactiguard AB.

Several new entrants are entering the market, intensifying the competition. These companies are focusing on developing low-cost products to gain a foothold in the market. These players include companies such as ASID BONZ GmbH, Amsino International Inc., and Fuqing Medical.

Key Segments

Type:

2 Way

3 Way

4 Way

Material:

Latex Foley Catheter

Hydrogel-coated Latex Foley Catheters

Silicon-coated Latex Foley Catheter

Silver-coated Latex Foley Catheters

PTFE (polytetrafluoroethylene) (Teflon)

Coated Latex Foley Catheters

Silicon Foley Catheter

Hydrogel-coated Silicone Foley Catheters

Pure Silicone Foley Catheters

Silver-coated Silicon Foley Catheters

Others

Indication:

Urinary Incontinence

Urethral Stricture

Chronic Obstruction

Neurogenic Bladder

Enlarged Prostate Gland/BPH

Prostate Cancer

Others

End User:

Hospitals

Long-term Care Facilities

Others

Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

The Middle East and Africa

#Foley Catheter Market

[neha24blog]

Foley Catheter Market Segmented On The Basis Of Product Type, Material, Indication, End-User, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 28 July 2023: The Report Foley Catheter Market Size, Share & Trends Analysis Report By Product Type (2-way, 3-way, 4-way), By Material (Silicone, Latex), By Indication (Urinary Incontinence, Enlarged Prostate Gland/BPH) , By End-user, By Region, And Segment Forecasts, 2023 – 2030 The global foley catheter market size is expected to reach USD 2.57 billion by 2030, expected to…

View On WordPress

#Foley Catheter Industry #Foley Catheter Market #Foley Catheter Market 2023 #Foley Catheter Market 2030 #Foley Catheter Market Revenue #Foley Catheter Market Share #Foley Catheter Market Size

[sparkgroup11]

#Foley Catheters Market

[wiseguy1122]

https://twikkers.nl/blogs/81038/Foley-catheters-Market-Share-Key-Companies-Profile-Sales-and-Cost

8th Nov 2022 Foley Catheters Market SWOT Analysis, Future Growth, Major Key Players, Opportunity and Forecast 2030

Foley Catheters market is experiencing a surge in sales across the globe, and it has been considerably boosted by technological advancement.

#Foley Catheters Market

[wisguy4567]

7th Nov 2022 Foley Catheters Market SWOT Analysis, Future Growth, Major Key Players, Opportunity and Forecast 2030

Foley Catheters market is experiencing a surge in sales across the globe, and it has been considerably boosted by technological advancement.

#Foley Catheters Market

[jesse-pinkman123]

The research report incorporates a detailed evaluation of this industry and a commendable brief of its segments. The study is inclusive of a basic overview of this market with respect to the current industry status and the market size, on the basis of volume and revenue.

#Foley Catheters Market Research #Foley Catheters Market Outlook

[ataleoftwopitties]

ASPERGILLOSIS IN DOGS

Aspergillosis is a fungal infection caused by a type of mold called Aspergillus. There are over 200 known species of Aspergillus fungi found worldwide that can grow either indoors or outdoors, and are commonly found in soil, dead or decaying vegetation, or spoiled food. They produce tiny asexual spores that can be easily inhaled or ingested, although do not generally lead to disease in humans or animals, unless the host has a compromised immune system or has significant exposure to the fungus.

SINONASAL ASPERGILLOSIS

In dogs, especially dolicocephalic (long-snout) breeds such as the Greyhound, Collie, and Dachshund, aspergillosis is typically localized to the nasal cavity/sinuses. Symptoms of sinonasal aspergillosis include chronic sneezing and bloody nasal discharge, classically from one nostril, and sometimes depigmentation and/or ulceration of the nares.

Mucous will eventually build up into a "fungal ball", or aspillergoma, which can be detected under advanced imaging.

In severe cases, there will be marked damage of the nasal turbinates and the infection spreads from within the sinus cavity through the frontal bone of the skull, invading into the brain and central nervous system. For this reason, CT scan is highly recommended along with a rhinoscopy.

Historically, treating fungal infections with oral medications are very challenging, as the infections are often very slow to clear, and many anti-fungals available on the market are not only expensive, but may have severe side effects including liver damage and neurological symptoms. Because of this, the debridement of fungal lesions followed by topical infusion have become the gold standard treatment, as long as the cribriform plate of the skull is intact.

While under anesthesia, fungal plaque is removed with the guidance of a scope in the nasal cavity. In some cases, however, fungal plaque may be located in the sinuses but not in the nasal cavity - in which case trephination may be performed. An incision is made along the forehead to remove a layer of bone to create access.

Once the aspergilloma is debrided, a clotrimazole (anti-fungal) solution is infused into the nose and frontal sinuses while the the back of the patient's throat is closed off with gauze and foley catheters. (The patient is able to breathe through an endotracheal tube.) Cotton swabs are used to plug the nostrils, and the clovtrimazole solution incubates for 30 minutes to 1 hour, as the patient is periodically rotated to allow even distribution throughout the sinuses and maximize penetration.

The clotrimazole solution is then drained out the nostrils and suctioned out. While this treatment has been shown to be highly effective, about 1/3 of patients may need repeat infusions.

If there is evidence that the infection has already eroded through the sinus bones and penetrated the brain, then the treatment described above may not be used, and oral medication would be recommended instead. Several months of treatment would be required, with a reported 60-70% success rate, compared to 86% observed in fungicide infusions.

DISSEMINATED ASPERGILLOSIS

Systemic aspergillosis occurs in dogs when the fungal spores diffuse past the respiratory system and enter the bloodstream, spreading to other sites within the body, including bone, spine, muscles, kidneys, as well as the eyes. A bronchopulmonary form of aspergillosis also forms in dogs, although rare.

Although less commonly diagnosed, disseminated aspergillosis is most often observed in young-middle aged female German Shepherds and most commonly associated with the A. terreus species. Many patients may also have underlying immunocompromise, such as diabetes mellitus or concurrent bacterial infections, or are receiving immunosuppressive medications, such as glucocorticoids or chemotherapeutics.

Clinical signs of disseminated aspergillosis are dependent on which organ(s) are involved, although many dogs may also show nonspecific signs such as anorexia, lethargy, and fever. Other symptoms of systemic involvement include weight loss, muscle wasting, hematuria, urinary incontinence, uveitis, and neurological deficits such as head tilt and ataxia. There are also often draining tracts (holes with pus or bloody discharge oozing out) in areas of infection.

Diagnosing disseminated aspergillosis can actually be quite difficult and invasive. Unfortunately, many dogs are often terminal by the time aspergillosis is suspected, and have an extensive history of failed antimicrobial treatment before diagnosis.

Treatment is also particularly frustrating for these cases, either requiring years - or even lifelong - administration of anti-fungal drugs, and regular follow-ups to monitor for any side effects. While some anti-fungals like iconazole and fluconazole are more cost-effective than others, they are not as effective clinically. On the other hand, the ones that are more effective, like voriconazole, are also more expensive and more toxic over time.

Often times, surgery may also be required to remove the source of the fungal infection (i.e. limb amputation, osteotomy, lung lobectomy, enucleation, etc.). Although surgery may sometimes be curative, prognosis is generally very guarded to poor, as many dogs will often die of their disease before medication can begin to control their condition, or if the surgery required is out of reach.

However, treatment should still be considered in dogs with less severe clinical signs. While treatment of an opportunistic fungal infection is very challenging, early recognition and aggressive treatment can enhance the chance for success.

Sources/Further Reading:

Ballber, Clara, et al. “Minimally invasive treatment of sino‐nasal aspergillosis in dogs.” Journal of Veterinary Internal Medicine, vol. 32, no. 6, 16 Oct. 2018, pp. 2069–2073, https://doi.org/10.1111/jvim.15311. 

Bennett, Peter F., et al. “Long term survival of a dog with disseminated Aspergillus deflectus infection without definitive treatment.” Medical Mycology Case Reports, vol. 22, Dec. 2018, pp. 1–3, https://doi.org/10.1016/j.mmcr.2018.07.002. 

Brooks, Wendy. “Aspergillosis in Dogs.” Veterinary Partner, VIN (Veterinary Information Network), 1 Nov. 2023, veterinarypartner.vin.com/default.aspx?pid=19239&id=4952634. 

Gull, Tamara. “Aspergillosis in Animals.” Merck Veterinary Manual, Merck & Co., Inc., Apr. 2023, www.merckvetmanual.com/generalized-conditions/fungal-infections/aspergillosis-in-animals. 

Nelson, Whitney, and Audrey K. Cook. “When to Consider Aspergillosis in Dogs.” DVM 360, MJH Life Sciences, 1 Aug. 2010, www.dvm360.com/view/when-consider-aspergillosis-dogs. 

Pascutti, Kristina, and Stuart A. Walton. “Approaches to Opportunistic Fungal Infections in Small Animals.” Today’s Veterinary Practice, 7 Apr. 2021, https://todaysveterinarypractice.com/internal-medicine/approaches-to-opportunistic-fungal-infections-in-small-animals/. 

Renchler, J.S. “A Review of Systemic Aspergillosis in Dogs.” Clinical Reviews, Mira Vista Veterinary Diagnostics, Oct. 2020, miravistavets.com/fungal-diseases/aspergillus/review-systemic-aspergillosis-in-dogs/. 

#aspergillosis #canine health #veterinary medicine #small animal internal medicine #fungal infection #sinonasal aspergillosis #disseminated aspergillosis #canine disease #dogs

[omkarpatel]

Foley Catheters Market will grow at highest pace owing to rising prevalence of urinary incontinence

Foley catheters are thin, flexible tubes inserted through the urethra and into the bladder to drain urine from the bladder. Foley catheters help drain urine from the bladder for patients who cannot urinate naturally due to various medical conditions. They are majorly used after surgeries of prostate, gynecology and urology to monitor urine output. The global Foley catheters market is primarily driven by rising prevalence of urinary incontinence mainly caused by neurological diseases and pelvic floor dysfunctions. Urinary incontinence affects millions of people globally, thereby increasing demand for short- and long-term catheterization procedures using Foley catheters. The Global Foley Catheters Market is estimated to be valued at US$ 1.64 billion in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the Foley catheters market are C.R. Bard, Inc., Teleflex Incorporated, Medtronic, Inc., ConvaTec, Inc., Medline Industries, Inc., B. Braun Melsungen AG, Create Medic Co. Ltd., Fuji Systems Corporation, and Cook Medical Group, Inc. Teleflex Incorporated held the largest market share in 2020 owing to its diverse product portfolio and strong distribution network globally. The growing geriatric population susceptible to urinary disorders is a major demand driver for Foley catheters. As per United Nations data, over 16% of the global population is expected to be aged 65 years and above by 2050. With age comes higher risks of urological conditions requiring catheterization. Technological advancements are further expanding the applications of Foley catheters. New product variants with anti-biofilm coatings, advanced materials and refined designs are enhancing patient comfort and clinical outcomes. Market Trends Single-use Foley catheters are gaining preference over multi-use models to prevent infections. The trend is driven by the preference of healthcare facilities to reduce operational costs by eliminating reprocessing requirements of multi-use catheters. Another key trend is the emergence of magnet-tipped Foley catheters facilitating catheter removal without the need for manual traction or anesthesia. The magnet-enabled technology promises to enhance patient comfort during catheter insertion and withdrawal procedures. Market Opportunities The untapped potential of emerging economies in Asia Pacific and Latin America presents lucrative opportunities for Foley catheter manufacturers. Furthermore, the rising demand for extended short-term catheterization during complex surgeries expands opportunities. Product innovations addressing unmet needs like catheters optimized for self-catheterization also present opportunities. The Impact of COVID-19 on Foley Catheters Market Growth The COVID-19 pandemic has severely impacted the growth of the Foley catheters market. During the initial outbreak, there was a significant rise in demand for Foley catheters as hospital admissions for COVID infections surged globally. However, with the lockdown restrictions imposed worldwide, the supply chain was disrupted which led to shortages and delays in product shipments. This negatively impacted market growth during 2020. As healthcare resources were diverted towards treating COVID patients, several elective surgeries and non-essential medical procedures that require Foley catheter usage were postponed. This caused a decline in demand. Currently, in terms of value, North America accounts for the largest share in the Foley catheters market owing to the high prevalence of target diseases, rising elderly population, and advanced healthcare infrastructure. Within the region, the United States holds the major market share and is expected to continue dominating over the forecast period. This is attributed to factors such as the high spending on healthcare, growing obese population suffering from urinary incontinence, and presence of leading market players.

#healthcare

[david843346]

Foley Trays Market: Global Demand Analysis & Opportunity Outlook 2036

Research Nester’s recent market research analysis on “Foley Trays Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global foley trays market in terms of market segmentation by material, end user, gender, indication, catheter type, and by region.

Growing Number of Surgical Procedures to Promote Global Market Share of Foley Trays

The global foley trays market is estimated to grow majorly on account of the increased number of surgical procedures taking place all across the globe. During the forecast period, demand in the market for foley trays will be increased due to increasing numbers of operating procedures which require postoperative care. Market demand for foley trays increases due to increasing awareness and increased use of treatment. Demand for foley trays is anticipated to rise as the growing elderly population becomes increasingly dependent on them. In the coming decade, demand for foley tray is expected to be driven by generous reimbursement policies in developed countries.

Request Report Sample@

Some of the major growth factors and challenges that are associated with the growth of the global foley trays market are:

Growth Drivers:

Surge in Geriatric Population

Rising Number of Surgical Procedures Taking Place

Challenges

The foley tray market is subject to a number of regulations that can make it difficult for manufacturers to bring new products to market. This can slow down innovation in the market. Furthermore, side effects associated with foley trays and the impact of covid-19 pandemic are some of the major factors anticipated to hamper the global market size of foley trays. A lockdown was put in place in some countries because of the COVID-19 pandemic, which led to a delay in production. As a consequence of restrictions imposed on the import and export activities at either side of the border affecting the market for foley trays, there is also evidence of supply chain disruption. As a result of the pandemic delaying the growth of the foley tray market, there has been a significant decrease in hospital visits and surgical procedures.

By indication, the global foley trays market is segmented into urinary incontinence, prostate cancer, bladder obstruction, spinal cord injury, urinary tract infection. The urinary incontinence segment is to cover half the market by the end of 2036 growing at a significant CAGR over the forecast period. A large prevalence of these diseases worldwide, with the United States alone having 1,229 to 627 urinary stricture cases per 100,000 men. In addition, due to the growing incidence of these cases, chronic obstruction and neurogenic urinary tract disease are expected to collectively account for a quarter of global value.

The market in the Asia Pacific region is estimated to grow substantially during the time period between 2024 – 2036. It is anticipated that recent developments in foley catheters would provide patients with even greater comfort and convenience, leading to a rise in use in the region. India ranks as one of the biggest economies in the world and has a sizable elderly population. Additionally, it is anticipated that India's elderly population will keep growing.

Access our detailed report at:

#Foley Trays Market

[imirmarketresearch]

#Foldable Display Market growth #imir

[kanewarner]

[reportsneww]

Neurological Biomarkers Market is anticipated to exhibit a CAGR of 11.9% from 2022 to 2030

Newark, New Castle, USA – Growth Plus Reports’ most recent study examines the Global Neurological Biomarkers Market’s production, prospective uses, demand, key companies, and SWOT analysis.

You may get insights into the TOC, and Statistics for essential facts, information, trends, and competitive landscape information.

Download Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/neurological-biomarkers-market/8040

The following are the leading companies in the Global Neurological Biomarkers market:

Abbott Laboratories Inc.

Quanterix Corporation

Thermo Fisher Scientific Inc.

Qiagen NV

Bio-Rad Laboratories Inc.

Merck KGaA

Banyan Biomarkers Inc.

Johnson & Johnson

ACOBIOM

Myriad Genetics Inc.

DiaGenic ASA

Olink Biosciences

Growth Plus Reports studies the key trends in each category and sub-segment of the Neurological Biomarkers market, along with Global and regional projections from 2023 to 2031. Our research splits the market into product type and application segments.

SEGMENTATION

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY TYPE

Genomic

Metabolomic

Proteomic

Imaging

Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY APPLICATION

Alzheimer’s Disease

Parkinson’s Disease

Multiple Sclerosis

Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY END-USER

Hospitals & Laboratories 

Independent Diagnostic Centers 

Research Organizations 

Others

For More Information or Query or Customization visit: https://www.growthplusreports.com/inquiry/customization/neurological-biomarkers-market/8040

Companies may utilize Neurological Biomarkers market report to get insights on market variables and any restraints that may affect the manufacturing of their product. Companies that are expanding abroad require thorough Global market research that includes real market data to assist with their marketing strategy. This Global market Neurological Biomarkers industry study analyzes important market dynamics and provides in-depth information and statistics to help companies flourish. This research report on the Neurological Biomarkers market takes advantage of advanced and professional approaches such as SWOT analysis and GRG Health’s unique GrowthMIX strategy.

This report is useful in addressing various essential issues for market participants, while also supporting them in making investments and leveraging the market opportunities.

Neurological Biomarkers Market TOC: https://www.growthplusreports.com/report/toc/neurological-biomarkers-market/8040

Market segment by Region/Country including: –

-North America (United States, Canada and Mexico) -Europe (Germany, UK, France, Italy, Russia and Spain etc.) -Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) -South America (Brazil, Argentina and Colombia etc.) -Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)

QUICK BUY: https://www.growthplusreports.com/checkout-8040

Browse Latest Healthcare Reports:

Cannabis Drugs Market

Sterilization Wrap Market

Foley Catheters Market

Thrombin Market

Trauma Implants Market

Urinary Drainage Bags Market

Genetic Disease Diagnostics Market

Veterinary Diagnostics Market

Intraoral Scanners Market

Immunodiagnostics Market

Neurodegenerative Disease Drugs Market

Pet Insurance Market

Contact Us:

Manan Sethi Director, Market Insights Email: [email protected] Phone no: [phone] Web: https://www.growthplusreports.com/

About Us Growth Plus Reports is part of GRG Health, a Global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.”

[wisguy4567]

7th Nov 2022 Foley Catheters Market SWOT Analysis, Future Growth, Major Key Players, Opportunity and Forecast 2030

Foley Catheters market is experiencing a surge in sales across the globe, and it has been considerably boosted by technological advancement.

#Foley Catheters Market

[globalcredibleanalyticsnews]

[globalenergypowernews]

[jean-perry]